<--- Back to Details
First PageDocument Content
Research / Pharmacology / Food and Drug Administration / MedWatch / Serious adverse event / Adverse event / Anosmia / Clinical research / Pharmaceutical sciences / Pharmaceutical industry
Research
Pharmacology
Food and Drug Administration
MedWatch
Serious adverse event
Adverse event
Anosmia
Clinical research
Pharmaceutical sciences
Pharmaceutical industry

Matrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued[removed], EIR signed[removed], and 483 issued[removed]pages)

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 54,31 KB

Share Document on Facebook

Similar Documents

Microsoft Word - SOP editedonlineversibaru.doc

Microsoft Word - SOP editedonlineversibaru.doc

DocID: 1rqX4 - View Document

Microsoft Word - Abbreviations List Approved Oct 2014

Microsoft Word - Abbreviations List Approved Oct 2014

DocID: 1qCp5 - View Document

Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses the

Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses the

DocID: 1qiz3 - View Document

Microsoft Word - Unanticipated_Problems

Microsoft Word - Unanticipated_Problems

DocID: 1pvDq - View Document

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015  Post marketing Control Division,

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,

DocID: 1p9e5 - View Document